{"classes":[{"categories":[{"measurements":[{"comment":"The curve that represents the upper confidence limit never crosses below 0.5 and therefore an upper bound for the median value cannot be calculated.","groupId":"OG000","lowerLimit":"10.81","upperLimit":"NA","value":"18.91"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"}],"units":"Participants"}],"description":"Overall survival defined as time from study entry to death","dispersionType":"95% Confidence Interval","groups":[{"description":"Galunisertib: Galunisertib 150mg po BID day 4-17\n\nPaclitaxel: Paclitaxel 175 mg/m2 over 3 hours\n\nCarboplatin: IV day 1 Carboplatin AUC 6\\* over 1 hour (or 5\\* if prior radiation therapy)","id":"OG000","title":"Paclitaxel/Carboplatin + Galunisertib"}],"paramType":"MEDIAN","populationDescription":"Patients who received at least four cycles of study drug","reportingStatus":"POSTED","timeFrame":"through study completion, an average of 3 years","title":"Median Overall Survival (Months)","type":"SECONDARY","unitOfMeasure":"months"}